Literature DB >> 23374619

Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study.

Cadman L Leggett1, Eric M Nelsen, Jianmin Tian, Cathy B Schleck, Alan R Zinsmeister, Kelly T Dunagan, G Richard Locke, Kenneth K Wang, Nicholas J Talley, Prasad G Iyer.   

Abstract

OBJECTIVES: To assess the association between Barrett esophagus (BE) and the metabolic syndrome in patients with and without reflux symptoms and to determine whether this association is reflux independent and metabolically driven. PATIENTS AND METHODS: Case patients with BE and controls were residents of Olmsted County, Minnesota (1999-2006). Two control groups (one with and one without symptoms of gastroesophageal reflux) were identified from a cohort of patients who had responded to a validated gastrointestinal symptom questionnaire. Cases and controls were individually matched by age, sex, and duration of follow-up. Controls did not have a known diagnosis of BE. The association of the metabolic syndrome and its individual components with BE was assessed using univariate and multivariate conditional logistic regression separately for each control group.
RESULTS: A total of 309 patients were included (103 BE cases, 103 controls with reflux symptoms, and 103 controls without reflux symptoms). A total of 64% of cases, 47% of controls with reflux symptoms, and 50% of controls without reflux symptoms had the metabolic syndrome. The metabolic syndrome was associated with a 2-fold increased risk of BE relative to those with (odds ratio, 2.00; 95% CI, 1.10-3.65; P=.02) and without (odds ratio, 1.90; 95% CI, 1.03-3.60; P=.04) reflux symptoms. This association was independent of smoking, alcohol consumption, and body mass index and remained robust with sensitivity analysis.
CONCLUSION: The metabolic syndrome is associated with BE independent of reflux symptoms, which may reflect a reflux-independent pathway of BE pathogenesis.
Copyright © 2013 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23374619      PMCID: PMC3771537          DOI: 10.1016/j.mayocp.2012.09.017

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  35 in total

1.  Clinical characteristics of asymptomatic esophagitis.

Authors:  Tsukasa Nozu; Hiroaki Komiyama
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

2.  Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; Bradley F Boeve; Robert J Ivnik; Vernon Shane Pankratz; Eric G Tangalos; Ronald C Petersen
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

3.  Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe.

Authors:  E Rey; G R Locke; H-K Jung; A Malhotra; R S Choung; T J Beebe; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2010-03-06       Impact factor: 8.171

4.  Prevalence and trends in obesity among US adults, 1999-2008.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Lester R Curtin
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

5.  Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups.

Authors:  S J Chung; D Kim; M J Park; Y S Kim; J S Kim; H C Jung; I S Song
Journal:  Gut       Date:  2008-04-25       Impact factor: 23.059

6.  Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state.

Authors:  Aoife M Ryan; Laura A Healy; Derek G Power; Miriam Byrne; Sinead Murphy; Patrick J Byrne; Dermot Kelleher; John V Reynolds
Journal:  Ann Surg       Date:  2008-06       Impact factor: 12.969

7.  Leptin and the risk of Barrett's oesophagus.

Authors:  B J Kendall; G A Macdonald; N K Hayward; J B Prins; I Brown; N Walker; N Pandeya; A C Green; P M Webb; D C Whiteman
Journal:  Gut       Date:  2008-01-04       Impact factor: 23.059

8.  Comparison of waist circumference with body mass index for predicting abdominal adipose tissue.

Authors:  Rie Oka; Katsuyuki Miura; Masaru Sakurai; Koshi Nakamura; Kunimasa Yagi; Susumu Miyamoto; Tadashi Moriuchi; Hiroshi Mabuchi; Masakazu Yamagishi; Yoshiyu Takeda; Senshu Hifumi; Akihiro Inazu; Atsushi Nohara; Masa-aki Kawashiri; Junji Kobayashi
Journal:  Diabetes Res Clin Pract       Date:  2008-11-18       Impact factor: 5.602

9.  Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus.

Authors:  Ai Kubo; Theodore R Levin; Gladys Block; Gregory J Rumore; Charles P Quesenberry; Patricia Buffler; Douglas A Corley
Journal:  Gastroenterology       Date:  2008-11-27       Impact factor: 22.682

10.  The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease.

Authors:  Y-C Lee; A M-F Yen; J J Tai; S-H Chang; J-T Lin; H-M Chiu; H-P Wang; M-S Wu; T H-H Chen
Journal:  Gut       Date:  2008-10-20       Impact factor: 23.059

View more
  24 in total

Review 1.  Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.

Authors:  Craig S Brown; Michael B Ujiki
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

Review 2.  Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus.

Authors:  Magnus Halland; David Katzka; Prasad G Iyer
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 3.  Gastrointestinal morbidity in obesity.

Authors:  Andres Acosta; Michael Camilleri
Journal:  Ann N Y Acad Sci       Date:  2014-03-06       Impact factor: 5.691

4.  Association of sporadic and familial Barrett's esophagus with breast cancer.

Authors:  M Q Chan; A E Blum; A K Chandar; A M L Kieber Emmons; Y Shindo; W Brock; G W Falk; M I Canto; J S Wang; P G Iyer; N J Shaheen; W M Grady; J A Abrams; P N Thota; K K Guda; A Chak
Journal:  Dis Esophagus       Date:  2018-04-01       Impact factor: 3.429

5.  Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.

Authors:  Jennifer Drahos; Winnie Ricker; Ruth M Pfeiffer; Michael B Cook
Journal:  Cancer       Date:  2016-11-08       Impact factor: 6.860

6.  Metabolic syndrome and the risk of Barrett's oesophagus in white males.

Authors:  A P Thrift; J Hilal; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2015-03-20       Impact factor: 8.171

7.  Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.

Authors:  Jennifer Drahos; Lin Li; Susan S Jick; Michael B Cook
Journal:  Cancer Epidemiol       Date:  2016-03-09       Impact factor: 2.984

8.  Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study.

Authors:  Prasad G Iyer; Bijan J Borah; Herbert C Heien; Ananya Das; Gregory S Cooper; Amitabh Chak
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-13       Impact factor: 11.382

9.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

10.  Obstructive sleep apnea is a risk factor for Barrett's esophagus.

Authors:  Cadman L Leggett; Emmanuel C Gorospe; Andrew D Calvin; William S Harmsen; Alan R Zinsmeister; Sean Caples; Virend K Somers; Kelly Dunagan; Lori Lutzke; Kenneth K Wang; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-11       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.